- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate
Have lost 10 lbs already So far its good Works well I do like would recommend on buying it
The mechanism matters, the data quality matters, and the gap between 'statistically significant in 12 rats' and 'FDA-approved therapy' matters even more
This isnt a generic supplement
Inositol: Another crucial ingredient that assists in turning food into energy
BPC-157 (Body Protection Compound-157): This synthetic peptide has shown potential in recovery and promoting tissue healing